Declining MMR vaccination coverage, hovering around 92.5% among kindergartners and well below the 95% herd immunity threshold, remains the dominant driver of sustained measles transmission in the United States. As of August 27, 2026, the CDC reported 2,903 confirmed cases for the year—already exceeding the full 2025 total of 2,289—with 94% outbreak-associated and 93–94% occurring in unvaccinated or unknown-status individuals. Cases span 47 jurisdictions, reflecting carryover from 2025 outbreaks plus new clusters. Official data show low hospitalization rates (7–8%) and no confirmed deaths to date. Weekly CDC surveillance updates and the November PAHO review of elimination status provide key upcoming data points that could influence final 2026 totals amid ongoing local transmission.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоВипадки кору в США в 2026 році?
Випадки кору в США в 2026 році?
$7,882,189 Обс.
$7,882,189 Обс.
Dec 31, 2026
↑4.5k
90%
↑3к
100%
↑3.5k
97%
↑4к
96%
↑5к
48%
↑7,5 тис.
9%
↑10 тис.
5%
↑12,5 тис.
2%
$7,882,189 Обс.
$7,882,189 Обс.
Dec 31, 2026
↑4.5k
$2,197 Обс.
90%
↑3к
$93,221 Обс.
100%
↑3.5k
$14,828 Обс.
97%
↑4к
$240,237 Обс.
96%
↑5к
$237,734 Обс.
48%
↑7,5 тис.
$190,278 Обс.
9%
↑10 тис.
$6,521,836 Обс.
5%
↑12,5 тис.
$356,093 Обс.
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Declining MMR vaccination coverage, hovering around 92.5% among kindergartners and well below the 95% herd immunity threshold, remains the dominant driver of sustained measles transmission in the United States. As of August 27, 2026, the CDC reported 2,903 confirmed cases for the year—already exceeding the full 2025 total of 2,289—with 94% outbreak-associated and 93–94% occurring in unvaccinated or unknown-status individuals. Cases span 47 jurisdictions, reflecting carryover from 2025 outbreaks plus new clusters. Official data show low hospitalization rates (7–8%) and no confirmed deaths to date. Weekly CDC surveillance updates and the November PAHO review of elimination status provide key upcoming data points that could influence final 2026 totals amid ongoing local transmission.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Ринок відкрито: Feb 16, 2026, 11:51 AM ET
Обсяг
$7,882,189Дата завершення
Jan 1, 2027Ринок відкрито
Feb 16, 2026, 11:51 AM ETВирішувач
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Declining MMR vaccination coverage, hovering around 92.5% among kindergartners and well below the 95% herd immunity threshold, remains the dominant driver of sustained measles transmission in the United States. As of August 27, 2026, the CDC reported 2,903 confirmed cases for the year—already exceeding the full 2025 total of 2,289—with 94% outbreak-associated and 93–94% occurring in unvaccinated or unknown-status individuals. Cases span 47 jurisdictions, reflecting carryover from 2025 outbreaks plus new clusters. Official data show low hospitalization rates (7–8%) and no confirmed deaths to date. Weekly CDC surveillance updates and the November PAHO review of elimination status provide key upcoming data points that could influence final 2026 totals amid ongoing local transmission.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Обсяг
$7,882,189Дата завершення
Jan 1, 2027Ринок відкрито
Feb 16, 2026, 11:51 AM ETВирішувач
0x65070BE91...Declining MMR vaccination coverage, hovering around 92.5% among kindergartners and well below the 95% herd immunity threshold, remains the dominant driver of sustained measles transmission in the United States. As of August 27, 2026, the CDC reported 2,903 confirmed cases for the year—already exceeding the full 2025 total of 2,289—with 94% outbreak-associated and 93–94% occurring in unvaccinated or unknown-status individuals. Cases span 47 jurisdictions, reflecting carryover from 2025 outbreaks plus new clusters. Official data show low hospitalization rates (7–8%) and no confirmed deaths to date. Weekly CDC surveillance updates and the November PAHO review of elimination status provide key upcoming data points that could influence final 2026 totals amid ongoing local transmission.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання